Brief: Soleno Therapeutics Inc - Withdraws Marketing Authorization Application For Viokat In Europe - SEC Filing
07/04/2026 12:09
April 7 (Reuters) - Soleno Therapeutics Inc SLNO.O: SOLENO THERAPEUTICS INC - WITHDRAWS MARKETING AUTHORIZATION APPLICATION FOR VIOKAT IN EUROPE - SEC FILING SOLENO THERAPEUTICS INC: DECISION TO WITHDRAW MAA IS BASED ON BUSINESS AND STRATEGIC CONSIDERATIONS Further company coverage: SLNO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Soleno Therapeutics
See all newsNASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: EMA's CHMP Recommends Granting A Marketing Authorisation For Cenrifki (Tolebrutinib)